Lip GYH - Search Results

1

Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients.

Deitelzweig S, Keshishian A, Li X, Kang A, Dhamane AD, Luo X, Balachander N, Rosenblatt L, Mardekian J, Pan X, Nadkarni A, Di Fusco M, Garcia Reeves AB, Yuce H, Lip GYH. Deitelzweig S, et al. Among authors: lip gyh. J Am Geriatr Soc. 2019 Aug;67(8):1662-1671. doi: 10.1111/jgs.15956. Epub 2019 May 21. J Am Geriatr Soc. 2019. PMID: 31112292 Free PMC article.

2

Quality of life in patients with atrial fibrillation: a systematic review.

Thrall G, Lane D, Carroll D, Lip GY. Thrall G, et al. Am J Med. 2006 May;119(5):448.e1-19. doi: 10.1016/j.amjmed.2005.10.057. Am J Med. 2006. PMID: 16651058 Review.

3

Effect of hypertension on anticoagulated patients with atrial fibrillation.

Lip GY, Frison L, Grind M; SPORTIF Invetigators. Lip GY, et al. Eur Heart J. 2007 Mar;28(6):752-9. doi: 10.1093/eurheartj/ehl504. Epub 2007 Feb 8. Eur Heart J. 2007. PMID: 17289744 Clinical Trial.

4

Improving stroke risk stratification in atrial fibrillation.

Lip GY, Halperin JL. Lip GY, et al. Am J Med. 2010 Jun;123(6):484-8. doi: 10.1016/j.amjmed.2009.12.013. Am J Med. 2010. PMID: 20569748 Review.

5

Does warfarin for stroke thromboprophylaxis protect against MI in atrial fibrillation patients?

Lip GY, Lane DA. Lip GY, et al. Am J Med. 2010 Sep;123(9):785-9. doi: 10.1016/j.amjmed.2010.01.031. Epub 2010 Jul 23. Am J Med. 2010. PMID: 20655037 Review.

6

Stroke prevention in atrial fibrillation patients.

Marinigh R, Lip GY, Lane DA. Marinigh R, et al. Expert Opin Pharmacother. 2010 Oct;11(14):2331-50. doi: 10.1517/14656566.2010.498819. Expert Opin Pharmacother. 2010. PMID: 20718589 Review.

7

Age as a risk factor for stroke in atrial fibrillation patients: implications for thromboprophylaxis.

Marinigh R, Lip GY, Fiotti N, Giansante C, Lane DA. Marinigh R, et al. J Am Coll Cardiol. 2010 Sep 7;56(11):827-37. doi: 10.1016/j.jacc.2010.05.028. J Am Coll Cardiol. 2010. PMID: 20813280 Free article. Review.

8

Current therapeutic strategies and future perspectives for the prevention of arterial thromboembolism: focus on atrial fibrillation.

Potpara TS, Lip GY. Potpara TS, et al. Curr Pharm Des. 2010;16(31):3455-71. doi: 10.2174/138161210793563400. Curr Pharm Des. 2010. PMID: 20858180 Review.

9

Implications of the CHA(2)DS(2)-VASc and HAS-BLED Scores for thromboprophylaxis in atrial fibrillation.

Lip GY. Lip GY. Am J Med. 2011 Feb;124(2):111-4. doi: 10.1016/j.amjmed.2010.05.007. Epub 2010 Sep 29. Am J Med. 2011. PMID: 20887966

10

Recent progress in antithrombotic therapy for atrial fibrillation.

Velu S, Lip GY. Velu S, et al. J Atheroscler Thromb. 2011;18(4):257-73. doi: 10.5551/jat.7153. Epub 2010 Nov 13. J Atheroscler Thromb. 2011. PMID: 21088368 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,432 results

Search Page